Skip to content

Atlas Venture Life Science Advisors, LLC

Follow

13F filer, CIK 1917529, CAMBRIDGE, MA

Atlas Venture Life Science Advisors, LLC reported $631,189,317 across 9 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-10.

Accepted , ingested 13F-HR 0001104659-26-125242

Period
2026-09-30
Reported value
$631M
Holdings
9
Top 10 weight
100%
New
2
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
OBXnew+4,503,149$61.8M
ODTXnew+2,692$59.8K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
DYNreduced-3,359,379-$54.1M
IRONreduced-129,850-$8.5M
KRROreduced-189,624-$1.88M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001104659-26-125242, largest first. % of portfolio is the value over $631,189,317, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,896,462 shares; 2025Q1: 4,896,462 shares; 2025Q2: 4,896,462 shares; 2025Q3: 4,896,462 shares; 2025Q4: 4,659,874 shares; 2026Q1: 4,578,008 shares; 2026Q2: 2,847,541 shares; 2026Q3: 2,847,541 shares 2,847,541$318M50.43%0Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,509,456 shares; 2025Q1: 2,384,456 shares; 2025Q2: 2,384,456 shares; 2025Q3: 2,142,617 shares; 2025Q4: 1,513,875 shares; 2026Q1: 1,513,875 shares; 2026Q2: 1,513,875 shares; 2026Q3: 1,384,025 shares 1,384,025$90.6M14.35%-129,850Timeline
OBXOBSIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,503,149 shares 4,503,149$61.8M9.8%newTimeline
KLRAKAILERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 5,171,282 shares; 2026Q3: 5,171,282 shares 5,171,282$59.1M9.36%0Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,019,354 shares; 2025Q1: 9,130,465 shares; 2025Q2: 9,130,465 shares; 2025Q3: 9,130,465 shares; 2025Q4: 9,130,465 shares; 2026Q1: 9,130,465 shares; 2026Q2: 6,800,099 shares; 2026Q3: 3,440,720 shares 3,440,720$55.4M8.78%-3,359,379Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,092,106 shares; 2025Q1: 2,092,106 shares; 2025Q2: 2,092,106 shares; 2025Q3: 2,092,106 shares; 2025Q4: 2,092,106 shares; 2026Q1: 2,092,106 shares; 2026Q2: 2,717,106 shares; 2026Q3: 2,717,106 shares 2,717,106$22.5M3.56%0Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 3,694,020 shares; 2025Q2: 3,694,020 shares; 2025Q3: 3,615,527 shares; 2025Q4: 2,995,602 shares; 2026Q1: 2,995,602 shares; 2026Q2: 2,995,602 shares; 2026Q3: 2,995,602 shares 2,995,602$15.8M2.5%0Timeline
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,137,149 shares; 2025Q1: 1,137,149 shares; 2025Q2: 1,137,149 shares; 2025Q3: 1,137,149 shares; 2025Q4: 1,137,149 shares; 2026Q1: 1,137,149 shares; 2026Q2: 962,884 shares; 2026Q3: 773,260 shares 773,260$7.66M1.21%-189,624Timeline
ODTXODYSSEY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,692 shares 2,692$59.8K0.01%newTimeline

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-26-125242 base2026-11-10